Budget Amount *help |
¥5,070,000 (Direct Cost: ¥3,900,000、Indirect Cost: ¥1,170,000)
Fiscal Year 2015: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2014: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Fiscal Year 2013: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Outline of Final Research Achievements |
Pyripyropene A, isolated from the culture broth of Aspergillus fumigatus FO-1289, is currently the only compound known to strongly and selectivity inhibit the acyl-CoA: cholesterol acyltransferase 2 (ACAT2) isozyme. To assist the development of new cholesterol-lowering or anti-atherosclerotic agents, we designed new A-ring truncated pyripyropene A analogs. We report here our successful synthesis of truncated analogs via a stereoselective intramolecular Michael cyclization method, and the construction of a 6-pyridyl-alfa-pyrone moiety.
|